PHAT
Phathom Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.01
+1.30%Forward multiples
Based on analyst estimates
- P/E forward
- 20.46x
- P/E 2026E
- —
- P/E 2027E
- 9.07x
- P/E 2028E
- 3.34x
- P/S forward
- 1.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.65x
- Price / sales
- 2.37x
- Price / cash flow
- -15.46x
Enterprise value
- Enterprise value
- $551.7M
- EV / sales
- 2.30x
- EV / EBITDA
- -15.70x
- EV / EBIT
- -13.58x
- Market cap
- $567.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026